Saturday, January 5, 2013

Second shareholder suit filed against KV - St. Louis Business Journal:

ogarawo.wordpress.com
KV’s management engaged in misconduct by failinf to recall unsafe drugs and that manufacturing disruptions had causexd a backlog of unshippedcustomer orders, eroding the company’a revenues and earnings, according to the KV also failed to write off at least $24 milliojn in inventories of discontinued products, the law firm A request for comment from KV was not immediately filed in as many monthxs against KV. Cohen Milstein Sellers Toll, which specializes in plaintiff class-action has offices in Washington, D.C.
; New York; Philadelphia; Chicago; and KV said it suspended shipments of all its drugs in tablet form and recallesd a single production lot of the painkiller Hydromorphone HCl 2 mg tablets becausw the tabletsare oversized. Mo.-based KV Pharmaceutical (NYSE: KVa, KVb) developxs and markets pharmaceutical products, includin branded and generic drugs.

No comments:

Post a Comment